Boris K Kurbatov

5PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersMolecular targetsBiomolecular modelling and designBiologically active moleculesCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 07, 2025
Metabolic syndrome reduces but does not eliminate the cardioprotective effect of adaptation to hypoxia: the link with changes in the opioid system.

Natalia V Naryzhnaya, Ivan A Derkachev, Boris K Kurbatov

|Jul 29, 2023
δ-Opioid Receptor as a Molecular Target for Increasing Cardiac Resistance to Reperfusion in Drug Development.

Natalia V Naryzhnaya, Alexander V Mukhomedzyanov, Maria Sirotina

|Mar 29, 2023
Apelin Is a Prototype of Novel Drugs for the Treatment of Acute Myocardial Infarction and Adverse Myocardial Remodeling.

Sergey V Popov, Leonid N Maslov, Alexandr V Mukhomedzyanov

|Jan 21, 2023
The Infarct-Reducing Effect of the δ2 Opioid Receptor Agonist Deltorphin II: The Molecular Mechanism.

Sergey V Popov, Alexandr V Mukhomedzyanov, Leonid N Maslov

|Aug 26, 2022
Production of Reactive Oxygen Species by Epicardial Adipocytes Is Associated with an Increase in Postprandial Glycemia, Postprandial Insulin, and a Decrease in Serum Adiponectin in Patients with Severe Coronary Atherosclerosis.

Natalia V Naryzhnaya, Olga A Koshelskaya, Irina V Kologrivova

Pageof 1

Frequent Collaborators

4 joint publications

Natalia V Naryzhnaya

4 joint publications

Alexandr V Mukhomedzyanov

4 joint publications

Leonid N Maslov

2 joint publications

Viacheslav N Azev